Xenon as an Adjuvant to Propofol Anaesthesia in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery.
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that the application of 30% xenon as an adjuvant to general
anesthesia with a target-controlled infusion of propofol is superior to general anesthesia
with propofol alone with respect to hemodynamic stability.